Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Endogenous peptide, involved in water/Na+ homeo...
Peptide, used as control to measure RGDS peptid...
Endogenous neuropeptide, somatostatin analog; s...
Sulforaphane-cysteine conjugate.
Endogenous peptide hormone inolved in gastric e...
Prenylflavinoid, derivative of xanthohumol foun...
Hedgehog and Smo agonist.
HEXIM1 activator.
Essential fatty acid found in fish oil, involve...
HIV integrase inhibitor.
Immunodominant peptide fragment of PLP, used to...
Peptide; GABA potentiator, NMDA negative allost...
Peptide, involved in feeding behavior and insul...
EZH2 inhibitor
Hexokinase inhibitor, aerobic glycolysis inhibi...
Peptide, protease substrate.
RARα/β agonist.
Nucleoside (deoxyguanosine) analog; DNA chain t...
ANP analog, cardiomodulatory peptide; NPR-A ago...
Endogenous NMDA receptor antagonist.